Divi's Laboratories Limited (BOM:532488)

Market Cap	1.80T
Revenue (ttm)	93.60B
Net Income (ttm)	21.91B
Shares Out	n/a
EPS (ttm)	82.53
PE Ratio	82.27
Forward PE	66.92
Dividend	30.00 (0.44%)
Ex-Dividend Date	Jul 25, 2025

Volume	1,730
Average Volume	7,807
Open	6,835.00
Previous Close	6,841.15
Day's Range	6,827.45 - 6,906.15
52-Week Range	4,396.60 - 7,077.70
Beta	n/a
RSI	54.58
Earnings Date	Aug 7, 2025

About Divi's Laboratories

Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as other finished forms, including lutein, and vitamins to food, dietary supplement, and feed manufacturers industries. It al...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1990
• Employees: 9,741
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 532488

Financial Performance

In 2024, Divi's Laboratories's revenue was 93.60 billion, an increase of 19.31% compared to the previous year's 78.45 billion. Earnings were 21.91 billion, an increase of 36.94%.